0 Commentaires
0 Parts
1KB Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Global Epidural and Spinal Anesthesia Drugs Market Growing at 5.1% CAGRAccording to a new report from Intel Market Research, the global epidural and spinal anesthesia drug market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.76 billion by 2034, exhibiting a steady CAGR of 5.1% during the forecast period (2026–2034). This growth is driven by increasing surgical volumes, rising preference for minimally...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Global Epidural and Spinal Anesthesia Drugs Market Growing at 5.1% CAGRAccording to a new report from Intel Market Research, the global epidural and spinal anesthesia drug market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.76 billion by 2034, exhibiting a steady CAGR of 5.1% during the forecast period (2026–2034). This growth is driven by increasing surgical volumes, rising preference for minimally...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Global Epidural and Spinal Anesthesia Drugs Market Growing at 5.1% CAGRAccording to a new report from Intel Market Research, the global epidural and spinal anesthesia drug market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.76 billion by 2034, exhibiting a steady CAGR of 5.1% during the forecast period (2026–2034). This growth is driven by increasing surgical volumes, rising preference for minimally...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Unfractionated Heparin Market Segmentation Analysis by Dosage Form and End UserThe global unfractionated heparin market continues to play a vital role in the healthcare industry due to the widespread use of anticoagulants in preventing and treating thromboembolic disorders. Unfractionated heparin (UFH) remains one of the most commonly used anticoagulant therapies in hospitals and clinical settings because of its rapid onset of action, established safety profile, and...0 Commentaires 0 Parts 649 Vue 0 Aperçu